赛诺医疗
(688108)
| 流通市值：55.63亿 | | | 总市值：55.63亿 |
| 流通股本：4.18亿 | | | 总股本：4.18亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 449,939,167.78 | 304,638,498.47 | 139,735,742.82 | 525,407,851.22 |
| 营业收入 | 449,939,167.78 | 304,638,498.47 | 139,735,742.82 | 525,407,851.22 |
| 二、营业总成本 | 356,878,818.13 | 234,886,791.58 | 110,756,427.78 | 478,178,733.38 |
| 营业成本 | 134,208,532.94 | 90,812,477.26 | 42,179,298.82 | 176,984,928.61 |
| 税金及附加 | 5,358,096.09 | 3,647,655.33 | 1,595,360.13 | 6,245,199.02 |
| 销售费用 | 56,560,121.99 | 35,373,715.58 | 18,094,229.69 | 77,525,348.41 |
| 管理费用 | 74,156,168.07 | 49,152,628.33 | 22,734,629.02 | 90,666,614.72 |
| 研发费用 | 83,682,251.71 | 53,713,574.96 | 25,025,511.31 | 122,570,643.31 |
| 财务费用 | 2,913,647.33 | 2,186,740.12 | 1,127,398.81 | 4,185,999.31 |
| 其中:利息费用 | 3,054,656.64 | 2,032,486.83 | 1,024,354.04 | 5,046,297.84 |
| 其中:利息收入 | 1,336,520.57 | 889,375.7 | 466,276.85 | 2,149,854.92 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 307,442.35 | 75,995.81 | - | - |
| 资产处置收益 | -1,590.71 | -1,590.71 | - | - |
| 资产减值损失(新) | -6,489,180.7 | -5,997,143.8 | -1,331,438.94 | -3,912,065.46 |
| 信用减值损失(新) | -4,687.3 | -35,076.16 | -29,649.82 | -265,624.72 |
| 其他收益 | 6,112,346.06 | 3,501,427.27 | 2,665,203.18 | 23,753,184.91 |
| 四、营业利润 | 92,984,679.35 | 67,295,319.3 | 30,283,429.46 | 66,804,612.57 |
| 加:营业外收入 | 175,808.53 | 153,468.76 | 1,297.01 | 2,237,957.33 |
| 减:营业外支出 | 389,361.8 | 289,169.49 | 125 | 596,655.73 |
| 五、利润总额 | 92,771,126.08 | 67,159,618.57 | 30,284,601.47 | 68,445,914.17 |
| 减:所得税费用 | 17,115,888.71 | 11,583,553.41 | 3,204,321.12 | 20,979,971.46 |
| 六、净利润 | 75,655,237.37 | 55,576,065.16 | 27,080,280.35 | 47,465,942.71 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 75,655,237.37 | 55,576,065.16 | 27,080,280.35 | 47,465,942.71 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 69,145,227.96 | 50,326,513.28 | 24,462,815.54 | 47,286,319.99 |
| 少数股东损益 | 6,510,009.41 | 5,249,551.88 | 2,617,464.81 | 179,622.72 |
| 扣除非经常损益后的净利润 | 65,567,738.96 | 48,708,252.76 | 23,121,787.27 | 33,955,505.95 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.17 | 0.12 | 0.06 | 0.11 |
| (二)稀释每股收益 | 0.17 | 0.12 | 0.06 | 0.11 |
| 八、其他综合收益 | -1,793,076.44 | -1,399,068.56 | -808,182.24 | -500,262.11 |
| 归属于母公司股东的其他综合收益 | -1,793,076.44 | -1,399,068.56 | -808,182.24 | -500,262.11 |
| 九、综合收益总额 | 73,862,160.93 | 54,176,996.6 | 26,272,098.11 | 46,965,680.6 |
| 归属于母公司股东的综合收益总额 | 67,352,151.52 | 48,927,444.72 | 23,654,633.3 | 46,786,057.88 |
| 归属于少数股东的综合收益总额 | 6,510,009.41 | 5,249,551.88 | 2,617,464.81 | 179,622.72 |
| 公告日期 | 2026-10-31 | 2026-08-27 | 2026-04-29 | 2026-03-26 |
| 审计意见(境内) | | | | 标准无保留意见 |